← All grants

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

National Institutes of Health · Opportunity PAR-28-062

Deadline January 25, 2027 138 days left
Award range Not stated
Total program funding
PostedAugust 31, 2026

Who can apply

Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

About this opportunity

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that invites applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered for funding. This funding opportunity seeks to support the Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI). The CAPRI Program establishes and strengthens comprehensive, mutually beneficial and meaningful partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs) to accelerate collaborative and innovative cancer. The Program achieves this by strategically building institutional capacity, advancing research capabilities, enhancing the impact of innovative cancer research, cultivating the next generation of Early-Stage Investigators and trainees, and implementing coordinated outreach and education initiatives that extend the benefits of research to all populations nationwide.

Award history — Cancer Control (Assistance Listing 93.399)

This program made 1 new award in FY2025.

New awards by fiscal year ’21: 5 · ’22: 14 · ’23: 7 · ’24: 13 · ’25: 1
Award size (min / median / max) $717k / $3M / $14.3M

Across the 40 most recent awards. Total obligations, not per-year.

Repeat winners 9 of 30 recipients won more than once

New awards recorded on USAspending.gov under the federal program that funds this opportunity. FY2025 figures may still be incomplete. Per-solicitation applicant counts are not published, so a true success rate for this specific opportunity cannot be computed. NIH publishes success rates by institute and activity code — source.

Apply on grants.gov →

Don't want to hunt for grants like this one? Get free deadline alerts for your state and focus areas.

Consultant or grant writer? See the client-ready Opportunity Brief for this grant — actual award sizes vs. the advertised ceiling, who wins, printable "prepared for your client" version.

Similar grants still open

OpportunityAgencyDeadlineAward ceilingEligible
NIH Director’s Pioneer Award (DP1 Clinical Trial Optional) National Institutes of Health September 9, 2026 0d left $700k Nonprofits
Fiscal Year 2027 Expanding Nutrition Services Health Resources and Services Administration September 9, 2026 0d left $350k
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional) National Institutes of Health September 10, 2026 1d left $350k Nonprofits
Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats Office of National Drug Control Policy September 13, 2026 4d left $300k Nonprofits